KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Inventory (2016 - 2025)

AbbVie (ABBV) has disclosed Change in Inventory for 14 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 80.47% to $25.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $234.0 million through Dec 2025, down 26.65% year-over-year, with the annual reading at $234.0 million for FY2025, 26.65% down from the prior year.
  • Change in Inventory for Q4 2025 was $25.0 million at AbbVie, up from -$2.0 million in the prior quarter.
  • The five-year high for Change in Inventory was $385.0 million in Q1 2022, with the low at -$219.0 million in Q3 2021.
  • Average Change in Inventory over 5 years is $89.9 million, with a median of $69.5 million recorded in 2024.
  • The sharpest move saw Change in Inventory plummeted 156.47% in 2023, then soared 233.33% in 2024.
  • Over 5 years, Change in Inventory stood at $112.0 million in 2021, then skyrocketed by 51.79% to $170.0 million in 2022, then tumbled by 156.47% to -$96.0 million in 2023, then skyrocketed by 233.33% to $128.0 million in 2024, then crashed by 80.47% to $25.0 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $25.0 million, -$2.0 million, and $56.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.